Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-1996 | 08-1993 | 08-1992 | 08-1991 | 08-1990 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 5,424 | 4,594 | 7,807 | 4,193 | 0 |
| TOTAL | $5,424 | $4,594 | $7,807 | $4,193 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,830 | 1,687 | 1,721 | N/A | N/A |
| Other Non-Current Assets | 5,654 | 6,926 | 6,815 | 7,061 | 0 |
| TOTAL | $10,484 | $8,613 | $8,536 | $7,061 | $N/A |
| Total Assets | $15,908 | $13,207 | $16,343 | $11,254 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,382 | 2,575 | 822 | 514 | N/A |
| Accounts payable and accrued liabilities | 2,224 | 1,256 | 2,220 | 1,027 | 0 |
| Accrued Expenses | 1,447 | 806 | 553 | 1,113 | N/A |
| Other current liabilities | 0 | 325 | 12 | 126 | N/A |
| TOTAL | $5,397 | $4,962 | $3,662 | $3,841 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $4 | $4 | $N/A |
| Total Liabilities | $5,397 | $4,962 | $3,666 | $3,845 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 70 | 53 | 53 | 38 | N/A |
| Other shareholders' equity | 169 | 55 | 0 | 0 | 0 |
| TOTAL | $14,259 | $9,577 | $9,502 | $3,300 | $N/A |
| Total Liabilities And Equity | $19,656 | $14,539 | $13,168 | $7,145 | $0 |